Skip to main content

Novel Gene Signature for Bladder Cancer Stage Identification

  • Conference paper
  • First Online:
Bioinformatics and Biomedical Engineering (IWBBIO 2023)

Part of the book series: Lecture Notes in Computer Science ((LNBI,volume 13919))

  • 379 Accesses

Abstract

This article presents a study that aimed to identify the stages of bladder cancer based on gene expression data. The dataset used in the study was obtained from the GDC repository and included 406 cases of bladder cancer and 431 files from the TCGA-BLCA project. The study categorized the cases into three classes based on disease stages: Stage 2, Stage 3, and Stage 4. The methodology employed R programming language and the KnowSeq library for the study development. The authors identified genes that showed significant differences in expression among the classes and created a matrix of differentially expressed genes (DEG). Machine learning models, including feature selection algorithms and classification models such as KNN and SVM, were constructed to predict the bladder cancer stages. The results revealed that the mRMR feature selection algorithm performed the best, and the 8 most relevant genes were used to build the classification models.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Andersen, J.B., Aaboe, M., Borden, E.C., Goloubeva, O.G., Hassel, B.A., Ørntoft, T.F.: Stage-associated overexpression of the ubiquitin-like protein, ISG15, in bladder cancer. Br. J. Cancer 94(10), 1465–1471 (2006). https://doi.org/10.1038/sj.bjc.6603099

  2. Castillo-Secilla, D., et al.: Knowseq r-bioc package: the automatic smart gene expression tool for retrieving relevant biological knowledge. Comput. Biol. Med. 133, 104387 (2021)

    Article  CAS  PubMed  Google Scholar 

  3. Fang, Z.Q., et al.: Gene expression profile and enrichment pathways in different stages of bladder cancer. Genet. Mol. Res. 12(2), 1479–1489 (2013). https://doi.org/10.4238/2013.may.6.1

  4. Hurst, C.D., et al.: Stage-stratified molecular profiling of non-muscle-invasive bladder cancer enhances biological, clinical, and therapeutic insight. Cell Rep. Med. 2(12), 100472 (2021). https://doi.org/10.1016/j.xcrm.2021.100472

  5. Li, M., et al.: 5-methylcytosine RNA methyltransferases and their potential roles in cancer. J. Transl. Med. 20(1) (2022). https://doi.org/10.1186/s12967-022-03427-2

  6. Siegel, R.L., Miller, K.D., Fuchs, H.E., Jemal, A.: Cancer statistics, 2022. CA Cancer J. Clin. 72(1), 7–33 (2022). https://doi.org/10.3322/caac.21708

  7. Stroggilos, R., et al.: Gene expression monotonicity across bladder cancer stages informs on the molecular pathogenesis and identifies a prognostic eight-gene signature. Cancers 14(10), 2542 (2022). https://doi.org/10.3390/cancers14102542

  8. Walker, C., Mojares, E., del Río Hernández, A.: Role of extracellular matrix in development and cancer progression. Int. J. Mol. Sci. 19(10), 3028 (2018). https://doi.org/10.3390/ijms19103028

  9. Zamanian Azodi, M., Rezaei-Tavirani, M., Rostami-Nejad, M., Rezaei-Tavirani, M.: Comparative bioinformatics characteristic of bladder cancer stage 2 from stage 4 expression profile: a network-based study. Galen Med. J. (Articles in Press), December 2018. https://doi.org/10.22086/gmj.v0i0.1279

  10. Zeng, X.T., Liu, X.P., Liu, T.Z., Wang, X.H.: The clinical significance of COL5a2 in patients with bladder cancer. Medicine 97(10), e0091 (2018). https://doi.org/10.1097/md.0000000000010091

  11. Zhang, X., et al.: High expression of COL6a1 predicts poor prognosis and response to immunotherapy in bladder cancer. Cell Cycle 22(5), 610–618 (2022). https://doi.org/10.1080/15384101.2022.2154551

Download references

Acknowledgements

This work was funded by the Spanish Ministry of Sciences, Innovation and Universities under Project PID2021-128317OB-I00 and the projects from Junta de Andalucia P20-00163.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Iñaki Hulsman .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this paper

Check for updates. Verify currency and authenticity via CrossMark

Cite this paper

Hulsman, I., Herrera, L.J., Castillo, D., Ortuño, F. (2023). Novel Gene Signature for Bladder Cancer Stage Identification. In: Rojas, I., Valenzuela, O., Rojas Ruiz, F., Herrera, L.J., Ortuño, F. (eds) Bioinformatics and Biomedical Engineering. IWBBIO 2023. Lecture Notes in Computer Science(), vol 13919. Springer, Cham. https://doi.org/10.1007/978-3-031-34953-9_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-34953-9_7

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-34952-2

  • Online ISBN: 978-3-031-34953-9

  • eBook Packages: Computer ScienceComputer Science (R0)

Publish with us

Policies and ethics